Serum Institute of India, the world's largest vaccine maker, is already mass producing and stockpiling AstraZeneca's Covishield shot, while Indian biotech players Bharat Biotech and Zydus Cadila are developing their own vaccine candidates.
New Delhi:
India will deploy its vast election machinery to deliver 600 million doses of COVID-19 vaccines to the most vulnerable people in the next six to eight months through conventional cold chain systems, the expert leading the initiative said on Friday.
The government has lined up cold storage facilities with temperatures between 2 to 8 degrees Celsius (36 to 48F), said V.K. Paul, who heads the group of experts on vaccine administration for COVID-19 that advises India's Prime Minister Narendra Modi.
Paul said these preparations meet the requirements of what he said were the four emerging candidates in the race for India's vaccine.
"The four that I can see, including Serum, Bharat, Zydus, and Sputnik need normal cold chain. I see no problem for these vaccines," he told Reuters in an interview.
Serum Institute of India, the world's largest vaccine maker, is already mass producing and stockpiling AstraZeneca's Covishield shot, while Indian biotech players Bharat Biotech and Zydus Cadila are developing their own vaccine candidates.
Conversations